OTC DEFICIENCY

Clinical trials for OTC DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new OTC DEFICIENCY trials appear

Sign up with your email to follow new studies for OTC DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Halted trial tests new injection for rare metabolic disorder

Disease control Terminated

This study aimed to test the safety and drug levels of an experimental medicine called ARCT-810 in people aged 12 and older with a rare genetic condition called ornithine transcarbamylase (OTC) deficiency. Participants received either the drug or a placebo via intravenous injecti…

Matched conditions: OTC DEFICIENCY

Phase: PHASE2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

OTC DEFICIENCY

Get alerted when new OTC DEFICIENCY trials appear

Halted trial tests new injection for rare metabolic disorder